RA-VII, a cyclic depsipeptide, changes the conformational structure of actin to cause G2 arrest by the inhibition of cytokinesis

Cancer Letters

Volumn 209, Issue 2, 2004, Pages 223-229

  Fujiwara, Hironori ^a   Saito, Shin Ya ^a   Hitotsuyanagi, Yukio ^b   Takeya, Koichi ^b   Ohizumi, Yasushi ^a  

^a TOHOKU UNIVERSITY   (Japan)

^b TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

Author keywords

Binucleation; F actin; G2 arrest; RA VII

Indexed keywords

ACTIN; ACTIN BINDING PROTEIN; ANTINEOPLASTIC AGENT; CYCLODEPSIPEPTIDE; F ACTIN; FLUORESCEIN ISOTHIOCYANATE; PHALLOIDIN; PROTEIN RA VII; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CANCER INHIBITION; CELL CYCLE G2 PHASE; CELL PROLIFERATION; CELL SHAPE; CONCENTRATION (PARAMETERS); CONCENTRATION RESPONSE; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; CYTOKINESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN STRUCTURE; RAT;

ACTINS; ANIMALS; CELL DIVISION; G2 PHASE; LEUKEMIA L1210; MICE; PC12 CELLS; PEPTIDES, CYCLIC; PHALLOIDINE; PROTEIN CONFORMATION; RATS; SURFACE PLASMON RESONANCE;

EID: 2442652440     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2003.12.022     Document Type: Article

References (24)

1. Schoenenberger C.A., Bischler N., Fahrenkrog B., Aebi U. Actin's propensity for dynamic filament patterning. Fed. Eur. Biochem. Soc. Lett. 529:2002;27-33
2. Carlier M.F., Ressad F., Pantaloni D. Control of actin dynamics in cell motility. Role of ADF/cofilin. J. Biol. Chem. 274:1999;33827-33830
3. Pollard T.D., Borisy G.G. Cellular motility driven by assembly and disassembly of actin filaments. Cell. 112:2003;453-465
4. Robinson D.N., Spudich J.A. Towards a molecular understanding of cytokinesis. Trends Cell. Biol. 10:2000;228-237
5. Senderowicz A.M., Kaur G., Sainz E., Laing C., Inman W.D., Rodriguez J., et al. Jasplakinolide's inhibition of the growth of prostate carcinoma cells in vitro with disruption of the actin cytoskeleton. J. Natl. Cancer Inst. 87:1995;46-51
6. Mookerjee B.K., Cuppoletti J., Rampal A.L., Jung C.Y. The effects of cytochalasins on lymphocytes.Identification of distinct cytochalasin-binding sites in relation to mitogenic response and hexose transport. J. Biol. Chem. 256:1981;1290-1300
7. Udagawa T., Yuan J., Panigrahy D., Chang Y.H., Shah J., D'Amato R.J. Cytochalasin E, an epoxide containing Aspergillus-derived fungal metabolite, inhibits angiogenesis and tumor growth. J. Pharmacol. Exp. Ther. 294:2000;421-427
8. Jordan M.A., Wilson L. Microtubules and actin filaments: dynamic targets for cancer chemotherapy. Curr. Opin. Cell. Biol. 10:1998;123-130
9. Ohizumi Y. Application of physiologically active substances isolated from natural resources to pharmacological studies. Jpn. J. Pharmacol. 73:1997;263-289
10. Fujiwara H., Matsunaga H.K., Saito M., Hagiya S., Furukawa K., Nakamura H., Ohizumi Y. Halenaquinone, a novel phosphatidylinositol 3-kinase inhibitor from a marine sponge, induces apoptosis in PC12 cells. Eur. J. Pharmacol. 413:2001;37-45
11. Fujiwara H., Matsunaga K., Kumagai K., Ishizuka M., Ohizumi Y. Ophiobolin A, a novel apoptosis-inducing agent from fungus strain f-7438, Pharm. Pharmacol. Commun. 6:2000;427-431
12. Kato T., Suzumura Y., Takamoto S., Ota K. Antitumor activity and toxicity in mice of RA-700, a cyclic hexapeptide. Anticancer Res. 7:1987;329-334
13. Vackova I., Engelova M., Marinov I., Tomanek M. Cell cycle synchronization of porcine granulosa cells in G1 stage with mimosine. Anim. Reprod. Sci. 77:2003;235-245
14. Bai R., Covell D.G., Liu C., Ghosh A.K., Hamel E. (-)-Doliculide, a new macrocyclic depsipeptide enhancer of actin assembly. J. Biol. Chem. 277:2002;32165-32171
15. Saito S., Watabe S., Ozaki H., Fusetani N., Karaki H. Mycalolide B, a Novel Actin Depolymerizing Agent. J. Biol. Chem. 269:1994;29710-29714
16. Nakatani K., Murayama T., Satoh Y., Furukawa K., Omura S., Ohizumi Y. Modulation of actomyosin ATPase by thiotetromycin is mediated through conformational change of actin. Eur. J. Pharmacol. 383:1999;381-386
17. Huang Z.J., Haugland R.P., You W.M., Haugland R.P. Phallotoxin and actin binding assay by fluorescence enhancement. Anal. Biochem. 200:1992;199-204
18. Itokawa H., Takeya K., Mori N., Takanashi M., Yamamoto H., Sonobe T., Kidokoro S. Cell growth-inhibitory effects of derivatives of antitumor cyclic hexapeptide RA-V obtained from Rubiae radix (V). Gann. 75:1984;929-936
19. Watabe S., Wada S., Saito S., Matsunaga S., Fusetani N., Ozaki H., Karaki H. Cellular changes of rat embryonic fibroblasts by an actin-polymerization inhibitor, bistheonellide A, from a marine sponge. Cell Struct. Funct. 21:1996;199-212
20. Wakita K.I., Minami M., Venkateswarlu A., Sharma V.M., Ramesh M., Akahane K. Antitumor bicyclic hexapeptide RA-VII modulates cyclin D1 protein level. Anticancer Drugs. 12:2001;433-439
21. Coluccio L.M., Tilney L.G. Phalloidin enhances actin assembly by preventing monomer dissociation. J. Cell. Biol. 99:1984;529-535
22. Cramer L.P. Role of actin-filament disassembly in lamellipodium protrusion in motile cells revealed using the drug jasplakinolide. Curr. Biol. 9:1999;1095-1105
23. Holzinger A., Lutz-Meindl U. Chondramides, novel cyclodepsipeptides from myxobacteria, influence cell development and induce actin filament polymerization in the green alga Micrasterias. Cell Motil. Cytoskeleton. 48:2001;87-95
24. Bubb M.R., Spector I., Beyer B.B., Fosen K.M. Effects of jasplakinolide on the kinetics of actin polymerization. An explanation for certain in vivo observations. J. Biol. Chem. 275:2000;5163-5170